Artificial Intelligence
Prostate Cancer Diagnosis and Therapy Market Worth USD 10.1 Billion by 2030 at 13.7% CAGR – Report by Market Research Future (MRFR)
New York, USA, July 06, 2022 (GLOBE NEWSWIRE) — Prostate Cancer Diagnosis and Therapy Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Prostate Cancer Diagnostics and Therapy Market Information by Type, Component, End-User, and Region – Forecast till 2030”, the prostate cancer diagnosis and therapy market will accrue a 13.7% CAGR between 2022 and 2030. By the end of 2030, the prostate cancer diagnosis and therapy market should touch USD 10.1 billion.
Prostate Cancer Diagnosis and Therapy Market Synopsis
Prostate cancer is one of the most commonly occurring non-cutaneous cancers globally. Steady increase in the geriatric population, prevalence of a sedentary lifestyle in developed economies, and the surging cases of urological disorder augment the development of prostate cancer worldwide.
The last few years have seen notable innovations in androgen receptor targeting with respect to prostate cancer. Other than this, advancements have been made in radiopharmaceutical-based therapy as well as immunotherapy, however; their optimal deployment in clinic is quite unclear. Significant advancements in prostate cancer diagnosis and therapeutics, such as abiraterone acetate, enzalutamide, cabazitaxel, radium-233 and sipuleucel-T have been made in the past couple of years.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1580
Report Scope:
| Report Attribute | Details |
| Market Size | USD 10.1 billion |
| CAGR | 13.7% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Component, Product and End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Market Drivers | Leading pharma to launch products for treatment |
| Diet that’s full of high-fat foods and junk food and smoking and heavy alcohol usage. |
Prostate Cancer Diagnosis and Therapy Market Competitive Landscape:
The affluent firms in the prostate cancer diagnosis and therapy market include
- Dendreon Pharmaceuticals LLC (US)
- Astellas Pharma Inc. (Japan)
- Bayer AG (Germany)
- Ipsen Pharma (France)
- Abbvie Inc. (US)
- Johnson & Johnson Services Inc. (US)
- AstraZeneca (UK)
- Tolmar Pharmaceuticals Inc. (US)
- Sanofi (France)
- Ferring BV (Switzerland)
Prostate Cancer Diagnosis and Therapy Market USP Covered:
Market Drivers:
Since the COVID-19 outbreak is a relatively new pandemic, the information about how it is related to prostate cancer is quite scarce. However, medical professionals confirm that cancer patients are at high risk of becoming severely ill in light of their weakened immune system. Those patients currently receiving treatments like chemotherapy, radiation therapy and bone marrow transplants are extremely susceptible to SARS-CoV-2. Even if the patient is not undergoing treatment therapy need to be careful as they are entirely out of danger from the virus. In short, the outbreak of the novel coronavirus has led to a higher need for prostate cancer diagnosis and therapy, which could result in further market growth.
Many of the healthcare related meetings such as oncology have become virtualized, since the worldwide lockdown. There has been a surge in the number of video or phone conferences, with the aim to maintain social distancing and prevent the spread of COVID-19. A majority of the urologists are being helpful in this situation; by bring down the demand for personal protective equipment, ventilators, and more by reducing surgeries while not compromising on the health of those afflicted with prostate cancer. In the coming years, the market for prostate cancer diagnosis and therapy can also benefit from the emergence of new generic products as the patents of various existing products are about to expire.
Renowned vendors and research teams worldwide are investing in research and development of various therapeutic items to treat prostate cancer. In addition to this, artificial intelligence is fast emerging as a significant trend in the global market, with its increasing use in cancer prognosis and diagnosis, thanks to its unprecedented level of accuracy.
Market Restraints:
Significant costs in association with targeted therapies for treating prostate cancer slow down the uptake of these therapies worldwide. Lower awareness level with regard to technological innovations in the therapeutic area in emerging countries is also likely to hamper the growth of the prostate cancer diagnosis and therapeutics market.
Chemotherapy generally displays poor response levels in later-stage of prostate cancer, and therefore, it is used as palliation for those with the hormone-refractory disease. The majority of the oncologists make no use of systemic therapies in the early phase of prostate cancer owing to the negative perception of early systemic therapy.
Prostate Cancer Diagnosis and Therapy Market COVID 19 Analysis
The COVID-19 outbreak’s significant impact has led to numerous severe repercussions on people’s health status across the world. The aftermath is linked with the significant social and economic burden on people worldwide. While the major policymakers are implementing new frameworks and industries are adopting advanced models of expansion to maintain their relevance, people are facing a series of mental trauma.
Around the world, the rising cases have spurred mental, and economic issues, especially among the elderly. Additionally, the global populace has been dealing with challenges owing to loss of livelihoods and is opting for family care to address the repercussions. The focus is largely on the treatment of COVID-19 and the development of a vaccine, which steers attention away from other markets. These factors will most likely be unfavorable for the prostate cancer diagnostics and therapy market in the years to come.
Browse In-depth Market Research Report (78 Pages) on Prostate Cancer Diagnosis and Therapy: https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580
Prostate Cancer Diagnosis and Therapy Market Segmentation
The market for Prostate Cancer Diagnosis and Therapy has been considered for type, product, component, and end user.
By Type
The primary types outlined in the market study are small cell carcinoma, prostatic adenocarcinoma, and more. The types of therapy are hormone therapy (luteinizing hormone-releasing hormone antagonists, antiandrogens and luteinizing hormone-releasing hormone analogs), chemotherapy (regional chemotherapy and systemic chemotherapy), biologic therapy, as well as targeted therapy.
By Product
The product-based key segments can be analyzers, consumables and reagents.
By Component
The main components studied in the report include therapy as well as diagnosis.
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=1580
By End-User
The key market end users as mentioned in the MRFR report are hospitals & clinics, specialty centers, and more. Despite the soaring number of ambulatory surgical centers that offer therapies for treating prostate cancer, hospitals and clinics still remain the most popular medium of health care. This has resulted in significant demand of prostate cancer therapeutics via hospital and clinics, which account for more than half of the market share.
Prostate Cancer Diagnosis and Therapy Market Regional Insights
The regional distribution of the Prostate Cancer Diagnosis and Therapy Market comprises Asia Pacific/APAC, the Americas, the Middle East & Africa/MEA as well as Europe.
Since the year 2018, Americas has remained the most lucrative market, as a result of the significant number of prostate cancer cases and the expansive geriatric population here. The well-developed healthcare infrastructure and the quick rate at which prostate cancer is treated in the early stages helps enhance the market size even further. The rich knowledge level with regard to prostate cancer diagnosis and therapy, particularly in the United States/US also facilitates market advancement in the region.
Share your Queries @ https://www.marketresearchfuture.com/enquiry/1580
As the second lead in the global market, Europe can continue thriving during the assessment period, with the immense growth in the elderly populace combined with the mounting awareness level with regard to cancer among people. The market growth in Europe is also the result of the several initiatives taken by the government with regard to prostate cancer.
There is a high possibility that the APAC market can obtain the fastest expansion rate in the forthcoming period, on account of the several health insurance plans and schemes and the improving financial conditions of the people. The consistent growth of the healthcare sector across China and India along with the alarming increase in obesity levels and the consequent rise in cases of prostate cancer are also presumed to be favorable for the APAC market in the long run.
Discover more research Reports on Healthcare Industry, by Market Research Future:
Brachytherapy Market Information by type (High dose-rate (HDR) brachytherapy, Low dose-rate (LDR) brachytherapy, Pulse Dose Rate (PDR) brachytherapy), by device (after loader and applicators) by application prostate cancer, cervical cancer, breast cancer, skin cancer, others)- Forecast till 2028
Intelligent Pills Market Information by Applications (Sleeping disorders, capsule endoscopy, Reflux Monitoring, Mobility Monitoring, Stress Management, and others), Prescription (prescription smart drugs and others) – Forecast to 2027
Cholesterol Management Devices Market Share, Growth And Trends Analysis Types (Monitors, Wrist Monitors, Small Portable Instruments, Meters, Wireless Systems), Application (Hypercholesterolemia, Hypocholesterolemia, Cholesterol Testing), End Users (Home Healthcare, Hospitals, And Clinics) – Forecast Till 2027
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Artificial Intelligence
MacPaw Recognized a Finalist in the Social Impact Award at the 2024 Reuters Events Sustainability Awards: Honored for Pioneering Innovation and Social Responsibility
KYIV, Ukraine, Oct. 2, 2024 /PRNewswire/ — MacPaw, a leading Ukrainian software company, has been named a finalist for the prestigious 2024 Reuters Sustainability Awards in the Social Impact category, standing out as the only Ukrainian company recognized in this field. This recognition highlights MacPaw’s exceptional efforts in ensuring safety, well-being, and innovation during adversity following the full-scale Russian invasion of Ukraine.
MacPaw’s entry, titled “Ensuring Safety and Well-being while Fostering Innovation: MacPaw’s Journey During Adversity,” underscores the company’s commitment to its employees and users, as well as the broader Ukrainian community. Despite the unprecedented challenges of wartime, MacPaw has continued to thrive, supporting millions of users across the world while spearheading vital social and humanitarian initiatives. We see Ukrainian innovation not only surviving but thriving. It’s a testament to Ukraine’s place in the tech world.
Key Achievements:
Humanitarian Aid and Recovery: Since February 2022, MacPaw has donated over $10 million to various charitable causes, driving significant change across Ukraine. MacPaw Foundation, a corporate charity, provided vital support to over 10,000 Ukrainians affected by the full-scale Russian invasion, ensuring they received the care and resources needed in times of adversity.Empowering Communities: Through the MacPaw Cares corporate social responsibility program, the company impacted 30+ social projects in 10 regions, focusing on supporting communities locally and globally, boosting sustainability effort, helping people in need, fostering local tech talent, inclusivity, and restoring access to education.Employee Support: The company implemented flexible mental health policies, offering dedicated support sessions, mental health surveys, and assistance to employees affected by the full-scale Russian invasion.Veterans Integration: MacPaw has launched a Veterans Integration Program to assist veterans in reintegrating into the company’s work and social life.Innovation in Crisis: Despite the war challenges, MacPaw introduced breakthrough products SpyBuster, ClearVPN, CleanMyPhone, Setapp Mobile. MacPaw also started a cybersecurity division that focuses exclusively on the cybersecurity needs of Mac users, Moonlock. Showcasing the commitment to the community, MacPaw developed Together App — a wartime check-in tool that helps employers monitor their team’s well-being and safety during the war.”We are honored to be recognized as Finalist in the Social Impact Award at the Reuters Events Sustainability Awards 2024 for our social impact efforts, especially as Russia’s invasion of Ukraine continues,” said Anna Manukhina, Director of MacPaw Foundation and CSR Lead at MacPaw. “This nomination reaffirms our commitment to supporting Ukraine and fostering innovation even in the times. Whether through mental health support, humanitarian aid, or product development, MacPaw’s initiatives reflect our mission to make a meaningful global impact.”
The 2024 Reuters Sustainability Awards are among the world’s most distinguished recognitions in sustainable development. It is more than just a recognition of the best sustainability strategies; it honors those who truly impact business, society, and the environment, creating a new way of doing business in the 21st century. Over the past 14 years, the award has served as a benchmark for companies worldwide.
For more information about MacPaw’s social impact initiatives, visit MacPaw’s Social Impact Review.
About MacPaw
MacPaw develops and distributes innovative software for macOS and iOS that simplifies the lives of Mac users. Renowned for its meticulously crafted products, such as CleanMyMac X, CleanMy®Phone, Setapp, and ClearVPN, and known for its Moonlock cybersecurity division, MacPaw is dedicated to enhancing and securing the Mac user experience. Founded in Kyiv, Ukraine, with offices in Boston, MacPaw serves millions of users worldwide. With one in every five Mac users having at least one MacPaw app, the company is a trusted leader in the Mac software ecosystem.
Photo: https://mma.prnewswire.com/media/2521457/Finalist_MACPAW.jpg
Media Contact: Oleksandra LytvynenkoPR [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/macpaw-recognized-a-finalist-in-the-social-impact-award-at-the-2024-reuters-events-sustainability-awards-honored-for-pioneering-innovation-and-social-responsibility-302265575.html
Artificial Intelligence
When Evaluating Vendors, 64% of Manufacturers Surveyed Cite Strong Onboarding and Ongoing Support as Crucial
NEW YORK, Oct. 2, 2024 /PRNewswire/ — Global technology intelligence firm ABI Research recently completed its 2024 Manufacturers’ Technology Adoption & Attitudes Survey, a comprehensive survey of 461 manufacturing decision-makers across the United States, Malaysia, and Germany to uncover real-world attitudes, adoption trends, and valuable insights that reflect the current technological landscape within the manufacturing industry. When asked which criteria were most important when evaluating a new solution or vendor, 64% of respondents ranked a robust onboarding process with training, resources, and post-sales follow-up as the most critical.
“Improving quality and productivity levels are key objectives for survey respondents. However, an overriding concern is how to deploy the technologies to achieve those objectives. Manufacturers require assurance that they will receive adequate support and training resources to quickly adapt, along with ongoing follow-up from the vendor,” explains Michael Larner, Distinguished Analyst at ABI Research.
Vendors often prioritize outlining potential investment outcomes to provide evidence of return on investment. Benefits will take longer to accrue if users cannot fully understand and properly utilize the solution. To avoid this, the vendor or their partners must be present during the initial launch, provide training resources that enable users to map the solution to their workflows, and adhere to a strict follow-up plan with the customer. These measures will require investment in the post-sales process, emphasizing partners’ education so that they effectively represent the vendor in onboarding processes.
The survey further revealed that recruiting and retaining staff is challenging for manufacturers. The lack of skills underscores the concerns not only regarding deploying technologies but also fully grasping the opportunities that digital technologies offer. “Hand holding by the vendor will be required when manufacturers are devising Proofs of Concept (PoCs), evaluating suppliers, and implementing solutions at their facilities,” Larner concludes.
These findings are from ABI Research’s Industrial and Manufacturing Survey 1H 2024: What Are Respondents Looking for from Vendors? report. This report is part of the company’s Industrial & Manufacturing Technologies research service, which includes research, data, and ABI Insights.
About ABI Research
ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.
ABI Research是一家全球性的技术情报公司，拥有得天独厚的优势，充当终端市场公司和技术解决方案提供商之间的桥梁，通过提供独家研究和专业性指导，推动成功的技术实施和提供经证明可吸引和留住客户的战略，无缝连接这两大主体。
For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.
Contact Info:
GlobalDeborah PetraraTel: [email protected]
Logo – https://mma.prnewswire.com/media/2309035/ABI_Research_2024.jpg
View original content:https://www.prnewswire.co.uk/news-releases/when-evaluating-vendors-64-of-manufacturers-surveyed-cite-strong-onboarding-and-ongoing-support-as-crucial-302265085.html
Artificial Intelligence
Scale Computing Offers Simple, Secure, Reliable IT Infrastructure to Guard Against Data-Hungry Ghouls
Company Gifting Retro Polaroid Cameras to End Users in North America and Europe, Middle East, and Africa through November 8th
INDIANAPOLIS, Oct. 2, 2024 /PRNewswire/ — Scale Computing, the market leader in edge computing, virtualization, and hyperconverged solutions, today announced its new campaign targeting outdated IT infrastructure and calling on organizations to learn more about Scale Computing Platform’s (SC//Platform) future-ready solutions. Between now and November 8, 2024, end users in North America and Europe, Middle East, and Africa (EMEA) who register for a meeting will receive a retro Polaroid camera.
“Downtime, data loss, and corruption can happen at any moment, threatening your business. Instead of being plagued by data-hungry ghouls and goblins, we invite users to learn more about Scale Computing and our SC//Platform to maximize security, ensuring that critical systems are always protected, validated, and ready for recovery. Organizations of all sizes across all vertical industries can benefit from SC//Platform, which brings together simplicity and scalability, replacing existing outdated infrastructure. Users instead get high availability for running workloads in a single, easy-to-manage platform, while leveraging our patented self-healing technology to maintain maximum uptime for all applications,” said Jeff Ready, CEO and co-founder of Scale Computing.
October is Cybersecurity Awareness Month, dedicated to raising awareness about the importance of digital security and protecting personal data. As cyber criminals become more sophisticated, maintaining modern infrastructure with a strong cybersecurity posture is key to keeping critical business applications and data secured. The new campaign from Scale Computing aims to help businesses scare away threats and fortify their defenses against data-hungry ghouls.
SC//Platform provides infrastructure that is simple, secure, scalable, and reliable. Combine it with Scale Computing’s subscription-based Business Continuity/Disaster Recovery (BCDR) Planning Service to establish a comprehensive and regulated response plan for any unforeseen downtime. With SC//Platform, an organization’s critical systems will be protected, validated, tested, and always ready for recovery when the goblins strike.
Book your meeting today to ensure your business is prepared for whatever data-hungry dark forces come your way and receive a complimentary Polaroid camera. To learn more about Scale Computing and book your meeting, visit https://www.scalecomputing.com/landing-pages/guard-against-data-hungry-ghouls.
About Scale ComputingScale Computing is a leader in edge computing, virtualization, and hyperconverged solutions. Using patented HyperCore™ technology, Scale Computing Platform automatically identifies, mitigates, and corrects infrastructure problems in real-time, enabling applications to achieve maximum uptime, even when local IT resources and staff are scarce. Edge Computing is the fastest-growing area of IT infrastructure, and industry analysts have named Scale Computing an outperformer and leader in the space, including being named the #1 edge computing vendor by CRN. Scale Computing’s products are sold by thousands of value-added resellers, integrators, and service providers worldwide. When ease-of-use, high availability, and TCO matter, Scale Computing Platform is the ideal infrastructure platform. Read what our customers have to say on Gartner Peer Insights, G2, and TrustRadius.
Logo – https://mma.prnewswire.com/media/2372470/Scale_Computing_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/scale-computing-offers-simple-secure-reliable-it-infrastructure-to-guard-against-data-hungry-ghouls-302264364.html
-
Artificial Intelligence5 days agoCluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
-
Uncategorized5 days agoMC Digital Realty wins Frost & Sullivan’s 2024 Japan Data Center Services Company of the Year Award
-
Artificial Intelligence5 days agoHyperlink InfoSystem Takes the Spotlight as a Top AI Development Company in USA 2024
-
Uncategorized5 days ago
Prime Minister concludes successful visit from President of France to Canada
-
Artificial Intelligence5 days agoHow AIoT shapes the future of mobility: Hikvision at ITS World Congress 2024
-
Artificial Intelligence5 days agoAnti-Drone Market worth $7.05 billion by 2029 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence3 days agoHuawei Wen Tong: 6G Needs to Embrace AI for Shaping Future Network
-
Artificial Intelligence5 days agoWondershare to Showcase Enterprise Solution Excellence at GITEX GLOBAL 2024
